Your browser doesn't support javascript.
loading
Neuroprotective effects of PPARα in retinopathy of type 1 diabetes.
Pearsall, Elizabeth A; Cheng, Rui; Matsuzaki, Satoshi; Zhou, Kelu; Ding, Lexi; Ahn, Bumsoo; Kinter, Michael; Humphries, Kenneth M; Quiambao, Alexander B; Farjo, Rafal A; Ma, Jian-Xing.
Afiliación
  • Pearsall EA; Angiogenesis Laboratory, Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA, United States.
  • Cheng R; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Matsuzaki S; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Zhou K; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
  • Ding L; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Ahn B; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Kinter M; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
  • Humphries KM; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
  • Quiambao AB; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
  • Farjo RA; Department of Biochemistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
  • Ma JX; EyeCRO LLC, Oklahoma City, OK, United States.
PLoS One ; 14(2): e0208399, 2019.
Article en En | MEDLINE | ID: mdl-30716067

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / PPAR alfa / Diabetes Mellitus Tipo 1 / Retinopatía Diabética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / PPAR alfa / Diabetes Mellitus Tipo 1 / Retinopatía Diabética Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos